Navigation Links
EntreMed Reports Clinical Program Progress and Company Update
Date:11/12/2008

ts. The Company is engaged in

partnering discussions for the Panzem(R) RA program.

Mr. Burns commented on the update, "Increased royalty revenues and strategic cost reductions should place the Company in a position to weather the current market conditions into 2010. Aggressive partnering efforts for our Aurora/angiogenesis inhibitor, ENMD-2076, are underway, which will help accelerate development of this exciting compound and provide the financial resources to maintain our clinical development plan. These are difficult market conditions but we will continue to be resilient in our strategies. While our stock price has suffered, we have continued to make excellent clinical progress. I am confident in our pipeline of multi-mechanism drugs for cancer and inflammatory diseases and I believe that we remain on course to achieve our clinical and partnering milestones."

About EntreMed

EntreMed, Inc. is a clinical-stage pharmaceutical company developing therapeutic candidates primarily for the treatment of cancer and inflammation. MKC-1, an oral cell-cycle regulator with activity against the mTOR pathway, is currently in multiple Phase 2 clinical trials for cancer. ENMD-2076, a selective angiogenic kinase inhibitor, and ENMD-1198, a novel antimitotic agent are in Phase 1 studies in advanced cancers. The Company also has an approved IND application for Panzem(R) in rheumatoid arthritis. EntreMed's goal is to develop and commercialize new compounds based on the Company's expertise in angiogenesis, cell cycle regulation, cell signaling and inflammation - processes vital to the treatment of cancer and other diseases, such as rheumatoid arthritis. Additional information about EntreMed is available on the Company's web site at http://www.entremed.com and in various filings with the Securities and Exchange Commission.

Forward Looking Statements

This release contains forward-looking state
'/>"/>

SOURCE EntreMed, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. EntreMed Receives Deloitte Technology Fast 50 Award
2. EntreMed to Present at the Bio 2007 Investor Forum
3. EntreMed Presents Results for Panzem(R) NCD Phase 2 Ovarian Cancer Study
4. EntreMed to Present at the Rodman and Renshaw 9th Annual Healthcare Conference
5. EntreMed Reports Third Quarter 2007 Financial Results
6. EntreMed Presents Results for ENMD-1198 and Vincristine in Preclinical Leukemia Models
7. EntreMed Announces FDA Acceptance of IND Application for Panzem(R) in Rheumatoid Arthritis
8. EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference
9. Dr. Ronald E. Cape to Retire from EntreMed Board of Directors
10. EntreMed Reports First Quarter 2008 Financial Results
11. EntreMed to Present at The Rodman and Renshaw 5th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2014)... NY (PRWEB) July 26, 2014 As ... magazine on July 23rd, new research by Palo Alto ... to rewrite their playbook, now focusing more on businesses ... masse who have become increasingly wise to their tactics ... founder and CEO/CTO, Joe Caruso, talks about the evolution ...
(Date:7/26/2014)... According to the Tinnitus ... this is a comprehensive guide that consists ... all types of disorders related to ... due to Ménière's disease ,     Objective ... tinnitus ,     Inner, middle or external ...
(Date:7/26/2014)... (PRWEB) July 26, 2014 “Healthy teeth are ... keeping those pearly whites shining,” says Community Health Center of ... Healthy ." , They believe that an integration of medical ... healthy and well. Because of this, they encourage regular cleanings ... with dentist . , “Children and adults will find ...
(Date:7/26/2014)... New York (PRWEB) July 26, 2014 ... to be filed in U.S. courts, Bernstein Liebhard LLP ... federal health regulators to ban uterine morcellation. According to ... a 46-year-old mother of four from California who was ... cancer called leiomyosarcoma just 10 days after undergoing a ...
(Date:7/26/2014)... Multiple sclerosis (MS), also known ... inflammatory disease in which the insulating covers of ... are damaged. This damage disrupts the ability of ... in a wide range of signs and symptoms, ... sclerosis takes several forms, with new symptoms either ...
Breaking Medicine News(10 mins):Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 2Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 3Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 4Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 5Health News:Businesses the New Target for Nigeria’s 419 Cyber-Scammers 6Health News:Tinnitus Miracle Book Review Exposes Thomas Coleman's Guide for Treating Tinnitus – Vkool.com 2Health News:Common Dental Care Questions Answered by Community Health Center of Snohomish County in Recent Article 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes New Calls for Ban on Uterine Mocellation In Light of Cancer Risk 4Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 2Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 3Health News:Multiple Sclerosis Therapeutics Clinical Trials Market Review H2 2014 Analysis Report Available at MarketOptimizer.org 4
... the journal Clinical Cardiology reveals that a Super Bowl ... in both men and women and in older individuals. , Sports ... the team loses, it can cause some degree of emotional stress. ... Institute, Good Samarian Hospital and Keck School of Medicine at USC ...
... real estate developer Douglas Rosenberg says he has a new ... Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist ... Bredesen, MD has the correct take on how to thwart ... The two have formed a unique partnership aimed at developing ...
... 29 (HealthDay News) -- Dry eye syndrome is common in ... heat, says an eye expert. Symptoms include pain, blurred ... as the eyes try to compensate for the dryness, explains ... and allergies can cause watery eyes, differentiating the two conditions ...
... Randy Dotinga HealthDay Reporter , FRIDAY, Jan. 28 ... percent of patients are considered difficult, and they,re more likely ... of the equation: Researchers also report that older doctors and ... patients. "The patients who have these kinds of problems ...
... that appears to contribute to blood vessel damage in ... Washington University School of Medicine in St. Louis. ... of the nearly 26 million Americans with the disease ... vision loss because of damaged vessels. Reporting in ...
... stress management techniques before prostate cancer surgery may help ... as well as aid in lowering mood disturbance, according ... of Texas MD Anderson Cancer Center. The ... journal Psychosomatic Medicine . It,s the first to ...
Cached Medicine News:Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 2Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 3Health News:Philanthropist invests $3.5 million in Buck Institute's Alzheimer's drug development effort 4Health News:Dry Eye Syndrome Common in Winter 2Health News:Docs Rate Almost 1 in 5 Patients as 'Difficult': Study 2Health News:Researchers discover root cause of blood vessel damage in diabetes 2Health News:Researchers discover root cause of blood vessel damage in diabetes 3Health News:Researchers discover root cause of blood vessel damage in diabetes 4Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 2Health News:Pre-surgical stress management boosts immune function, lowers mood disturbance in prostate cancer patients 3
(Date:7/25/2014)... 25, 2014  Corporate libraries are constantly being faced ... in technology and how to cope with flat or ... pharmaceutical and medical device industries are increasingly finding it ... services they provide. According to recent ... many forces of change that leading corporate libraries are ...
(Date:7/25/2014)... CHAPEL HILL, N.C. , July 25, 2014 /PRNewswire/ ... therapeutic area is costly and challenging - as is ... area. Is it possible - or ... products together? If so, where can you combine resources ... remain separated? These are just a ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- "Australia Capsule Endoscopy Systems Market Outlook to ... Endoscopy Systems market. The report provides value, in millions ... (in US dollars) within market segments: Photo ... Endoscopes , Capsule Endoscopy Data Recorders , ... provides company shares and distribution shares data for each ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... FRANCISCO, Jan. 29 Inverseon, Inc.,( http://www.inverseon.com ) ... trial in asthma., In the article by ... 21, (2008), pp. 134-141, entitled, "The safety and,effects ... open-label pilot,study," mild asthmatics were treated for 9 ...
... New Patient Data Posted Online Shows Improvements Across ... The Cystic Fibrosis,Foundation reported today that key indicators ... lung function and nutritional status -- are,rising nationwide ... fact, the outlook for people with CF continues ...
Cached Medicine Technology:Inverseon Announces Positive Phase IIa Asthma Study 2Cystic Fibrosis Foundation Reports Upward Trend for Key Health Outcomes 2
... when people are in need of MRI ... the tunnel-type scanners. They have heard of, ... highly claustrophobic and noisy tubes of supercon ... them. What people want is a patient-friendly ...
... spectrofluorometer is the ... among the FLUORAT®-02 ... intended for scientific ... and for operation ...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
... The BTF-111 miniature ... a user-con?gured spectrometer for ... nm. Con?gurable excitation light ... ?exibility of 2D ?uorescence ...
Medicine Products: